Although the potential mechanisms behind this interaction could be crucial for our understanding of the RA signaling pathway’s role in limiting HCC, there is the need to better define whether AFP binds to or acts on specific RARs. The gene discussed is RARS1; the disease is hepatocellular carcinoma.